A large-scale mathematical model, the Entelos® Rheumatoid Arthritis (RA) PhysioLab® platform, has been developed to describe the inflammatory and erosive processes in afflicted joints of people suffering from RA. The platform represents the life cycle of inflammatory cells, endothelium, synovial fibroblasts, and chondrocytes, as well as their products and interactions. The interplay between these processes culminates in clinically relevant measures for inflammation and erosion. The simulation model is deterministic, which allows tracing back the mechanism of action for a particular simulation result. Different patient phenotypes are represented by different virtual patients. The RA PhysioLab platform has been used to systematically and quantitatively study the predicted therapeutic effect of modulating several molecular targets, which resulted in a ranking of putative drug targets and a workflow to confirm the simulations experimentally. In addition, critical pathways were identified that drive the predicted disease outcome. Within these pathways, targets were identified from public literature that were not previously associated with arthritis. The model provides insights into the biology of RA and can be used as a platform for hypothesis-driven research. Case studies of therapies directed against IL-12 and IL-15 illustrate the approach, with emphasis on the analysis of system dynamics.
References
-
-
1)
-
M.C. Kraan ,
R.J. Reece ,
E.C. Barg ,
T.J. Smeets ,
J. Farnell ,
R. Rosenburg
.
Modulation of inflammation and metalloproteinase expression in synovial tissue by leflunomide and methotrexate in patients with active rheumatoid arthritis. Findings in a prospective, randomized, double-blind, parallel-design clinical trial in thirty-nine patients at two centers.
Arthritis Rheum.
,
1820 -
1830
-
2)
-
S. Ye ,
P. Eriksson ,
A. Hamsten ,
M. Kurkinen ,
S.E. Humphries ,
A.M. Henney
.
Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression.
J. Biol. Chem.
,
13055 -
13060
-
3)
-
G.S. Firestein ,
M.M. Paine ,
D.L. Boyle
.
Mechanisms of methotrexate action in rheumatoid arthritis. Selective decrease in synovial collagenase gene expression.
Arthritis Rheum.
,
193 -
200
-
4)
-
A.A. van Everdingen ,
J.W. Jacobs ,
D.R. Siewertsz Van Reesema ,
J.W. Bijlsma
.
Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trial.
Ann. Intern. Med.
,
1 -
12
-
5)
-
M. Aylward ,
J. Maddock ,
R. Wheeldon ,
R.J. Parker
.
A study of the influence of various antirheumatic drug regimens on serum acute-phase proteins, plasma tryptophan, and erythrocyte sedimentation rate in rheumatoid arthritis.
Rheumatol. Rehabil.
,
101 -
114
-
6)
-
S. Michelson
.
Assessing the impact of predictive biosimulation on drug discovery and development.
J. Bioinform. Comput. Biol.
,
169 -
177
-
7)
-
P. Sacerdote ,
M. Carrabba ,
A. Galante ,
R. Pisati ,
B. Manfredi ,
A.E. Panerai
.
Plasma and synovial fluid interleukin-1, interleukin-6 and substance P concentrations in rheumatoid arthritis patients: effect of the nonsteroidal antiinflammatory drugs indomethacin, diclofenac and naproxen.
Inflamm. Res.
,
486 -
490
-
8)
-
N. Walsh
.
Preliminary data mixed on IL-15 as RA target.
Rheumatology News
,
1
-
9)
-
I.B. McInnes ,
J.A. Gracie
.
Targeting cytokines beyond tumor necrosis factor-α and interleukin-1 in rheumatoid arthritis.
Curr. Rheumatol. Rep.
,
336 -
342
-
10)
-
J.R. Kirwan
.
The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The arthritis and rheumatism council low-dose glucocorticoid study group.
N. Engl. J. Med.
,
142 -
146
-
11)
-
A. Balsa ,
C. Gamallo ,
E. Martin-Mola ,
J. Gijon-Banos
.
Histologic changes in rheumatoid synovitis induced by naproxen and methotrexate.
J. Rheumatol.
,
1472 -
1477
-
12)
-
I.B. McInnes ,
B.P. Leung ,
R.D. Sturrock ,
M. Field ,
F.Y. Liew
.
Interleukin-15 mediated T cell-dependent regulation of tumor necrosis factor-α production in rheumatoid arthritis.
Nature Med.
,
189 -
195
-
13)
-
S. Reykdal ,
K. Steinsson ,
K. Sigurjonsson ,
A. Brekkan
.
Methotrexate treatment of rheumatoid arthritis: effects on radiological progression.
Scand. J. Rheumatol.
,
221 -
226
-
14)
-
E.R. Pettipher ,
B. Henderson ,
J.C. Edwards ,
G.A. Higgs
.
Effect of indomethacin on swelling, lymphocyte influx, and cartilage proteoglycan depletion in experimental arthritis.
Ann. Rheum. Dis.
,
623 -
627
-
15)
-
S. Cohen ,
G.W. Cannon ,
M. Schiff ,
A. Weaver ,
R. Fox ,
N. Olsen
.
Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of leflunomide in the treatment of rheumatoid arthritis trial investigator group.
Arthritis Rheum.
,
1984 -
1992
-
16)
-
A. Constantin ,
V. Lauwers-Cancès ,
F. Navaux ,
M. Abbal ,
J. van Meerwijk ,
B. Mazières ,
A. Cambon-Thomsen ,
A. Cantagrel
.
Stromelysin 1 (matrix metalloproteinase 3) and HLA-DRB1 gene polymorphisms.
Arthritis Rheum.
,
1754 -
1762
-
17)
-
D.G. Malone ,
R.L. Wilder ,
A.M. Saavedra-Delgado ,
D.D. Metcalfe
.
Mast cell numbers in rheumatoid synovial tissues. Correlations with quantitative measures of lymphocytic infiltration and modulation by antiinflammatory therapy.
Arthritis Rheum.
,
130 -
137
-
18)
-
J.S. Smolen ,
G. Steiner
.
Therapeutic strategies for rheumatoid arthritis.
Nature Rev. Drug Disc.
,
473 -
488
-
19)
-
K. Hall ,
R. Baillie ,
S. Michelson
.
Biosimulation: dynamic modeling of biological systems.
Annual Report Med. Chem.
,
279 -
288
-
20)
-
P.E. Lipsky ,
D.M. van der Heijde ,
E.W. St Clair ,
D.E. Furst ,
F.C. Breedveld ,
J.R. Kalden
.
Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study group.
N. Engl. J. Med.
,
1594 -
1602
-
21)
-
E.C. Huskisson ,
H. Berry ,
P. Gishen ,
R.W. Jubb ,
J. Whitehead
.
Effects of antiinflammatory drugs on the progression of osteoarthritis of the knee. LINK study group. Longitudinal investigation of nonsteroidal antiinflammatory drugs in knee osteoarthritis.
J. Rheumatol.
,
1941 -
1946
-
22)
-
A.M. van Gestel ,
R.F. Laan ,
C.J. Haagsma ,
L.B. van de Putte ,
P.L. van Riel
.
Oral steroids as bridge therapy in rheumatoid arthritis patients starting with parenteral gold. A randomized double-blind placebo-controlled trial.
Br. J. Rheumatol.
,
347 -
351
-
23)
-
R.J. Dolhain ,
P.P. Tak ,
B.A. Dijkmans ,
P. De Kuiper ,
F.C. Breedveld ,
A.M. Miltenburg
.
Methotrexate reduces inflammatory cell numbers, expression of monokines and of adhesion molecules in synovial tissue of patients with rheumatoid arthritis.
Br. J. Rheumatol.
,
502 -
508
-
24)
-
M.E. Jeurissen ,
A.M. Boerbooms ,
L.B. van de Putte ,
W.H. Doesburg ,
A.M. Lemmens
.
Influence of methotrexate and azathioprine on radiologic progression in rheumatoid arthritis. A randomized, double-blind study.
Ann. Intern. Med.
,
999 -
1004
-
25)
-
H.V. Westerhoff ,
B.O. Palsson
.
The evolution of molecular biology into systems biology.
Nature Biotechnol.
,
1249 -
1252
http://iet.metastore.ingenta.com/content/journals/10.1049/ip-syb_20050053
Related content
content/journals/10.1049/ip-syb_20050053
pub_keyword,iet_inspecKeyword,pub_concept
6
6